|
|
|
Upgrades: NVS, NKE, HBAN
September 30, 2009
After the bell yesterday, Citigroup upgraded shares of Swiss pharmaceutical company Novartis (NVS) from Hold to Buy as respiratory drugs and blood pressure medication should boost earnings over the coming quarters. The company's high blood pressure medication Diovan is expected to have strong sales for a prolonged period of time and should expand the company's margins.
Copyright (2009) Market News Video.
|
|
|